ENTITY
Hugel Inc

Hugel Inc (145020 KS)

63
Analysis
Health Care • South Korea
Hugel, Inc. is a Bio-pharmaceutical company that focuses on developing beauty/cosmetics related products. The Company's main products include botulinum toxin and fillers.
more
bullish•Eubiologics
•13 Oct 2021 00:28

EuBiologics (206650 KS): Cashing on Vaccine Business

Eubiologics is on a stable growth path, driven by increasing demand of its oral cholera vaccine business. Upcoming commercialization of COVID-19...

Logo
932 Views
Share
bearish•Hugel Inc
•15 Aug 2021 05:44

The Fight to Acquire Hugel - GS Group Led Consortium or Goldman Sachs Led Consortium?

The fight to acquire Hugel Inc (145020 KS) is now finally down to between the GS Group led consortium and the Goldman Sachs led consortium.

Logo
567 Views
Share
bearish•Hugel Inc
•29 Jun 2020 18:11

Hugel Placement: A 5.2% Block Deal Sale

After the market close today, it was reported that BK Medical Group’s Chairman Dr. Kim Byung-Gun and Dr. BK Corp will sell their 5.2% stake...

Logo
477 Views
Share
•28 Mar 2019 07:36

Daewoong: Entering "Botox World"

Daewoong Pharmaceutical Co (069620 KS) has traded up over the past year in anticipation of the launch of its botulinum toxin product Jeuveau in the...

Share
bearish•Sejong Medical Co Ltd
•09 May 2018 11:46

Sejong Medical IPO Preview (Part 2) - Valuation Analysis

Sejong Medical Comparable Companies Valuation AnalysisWe are negative on the Sejong Medical IPO. The four major comps that the bankers used for...

Logo
321 Views
Share
x